𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer

✍ Scribed by Nicholas J. Osborne; Lyle C. Gurrin; Katrina J. Allen; Clare C. Constantine; Martin B. Delatycki; Christine E. McLaren; Dorota M. Gertig; Gregory J. Anderson; Melissa C. Southey; John K. Olynyk; Lawrie W. Powell; John L. Hopper; Graham G. Giles; Dallas R. English


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
126 KB
Volume
51
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


The evidence that mutations in the HFE gene for hemochromatosis are associated with increased cancer risk is inconsistent. The Melbourne Collaborative Cohort Study is a prospective cohort study that commenced recruitment in 1990. Participants born in Australia, New Zealand, the United Kingdom, or Ireland (n ‫؍‬ 28,509) were genotyped for the HFE C282Y (substitution of tyrosine for cysteine at amino acid 282) variant. Incident cancers were ascertained from Australian cancer registries during an average of 14 years follow-up. Hazard ratios (HRs), confidence intervals (CIs), and P values were obtained from separate Cox regression analyses for colorectal, breast, and prostate cancers, all other solid cancers, and all cancers. Compared to those with no C282Y variant, C282Y homozygotes were at increased risk of colorectal cancer (HR ‫؍‬ 2.28; 95% CI ‫؍‬ 1.22, 4.25; P ‫؍‬ 0.01) and female C282Y homozygotes were at increased risk of developing breast cancer (HR ‫؍‬ 2.39; 95% CI ‫؍‬ 1.24, 4.61; P ‫؍‬ 0.01), but male C282Y homozygotes were not at increased risk for prostate cancer (HR ‫؍‬ 0⅐96; 95% CI ‫؍‬ 0⅐43, 2⅐15; P ‫؍‬ 0.92). C282Y/H63D compound heterozygotes were not at increased risk for colorectal cancer (HR ‫؍‬ 1.27; 95% CI ‫؍‬ 0.80, 2.01), breast cancer (HR ‫؍‬ 1.16; 95% CI ‫؍‬ 0.74, 1.84), or prostate cancer (HR ‫؍‬ 1.08; 95% CI ‫؍‬ 0.68, 1.70). Conclusion: HFE C282Y homozygotes have twice the risk of colorectal and breast cancer compared with those individuals without the C282Y variant. (HEPATOLOGY 2010;51:1311-1318.) See Editorial on Page 1119.

T he essential trace element iron can be carcinogenic through a variety of mechanisms including catalyzing the formation of mutagenic hydroxyl radicals, 1 suppression of the host immune response, 2 and by acting as an essential nutrient for proliferating tumor cells. 3 Hereditary hemochromatosis is an inherited disorder of iron overload characterized by inappropriately elevated intestinal iron absorption. In HFE-associated hereditary hemochromatosis, mutations in the HFE gene can impair synthesis of the master iron-regulatory protein hepcidin. Reduced hepcidin levels leads to increased release of iron from intestinal cells and macrophages, ele-Abbreviations: C282Y, substitution of tyrosine for cysteine at amino acid 282; CI, confidence interval; H63D, substitution of aspartic acid for histidine at amino acid 63; HFE, hemochromatosis protein; HR, hazards ratio.


📜 SIMILAR VOLUMES


HFE C282Y/H63D compound heterozygotes ar
✍ Lyle C. Gurrin; Nadine A. Bertalli; Gregory W. Dalton; Nicholas J. Osborne; Clar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

The risk of hemochromatosis-related morbidity is unknown among HFE compound heterozygotes (C282Y/H63D). We used a prospective population-based cohort study to estimate the prevalence of elevated iron indices and hemochromatosis-related morbidity for compound heterozygotes. In all, 31,192 subjects of

Women with Saethre-Chotzen syndrome are
✍ Pelle Sahlin; Per Windh; Claes Lauritzen; Monica Emanuelsson; Henrik Grönberg; G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract The Saethre‐Chotzen syndrome is an autosomal, dominantly inherited craniosynostosis caused by mutations in the basic helix‐loop‐helix transcription factor gene __TWIST1__. This syndrome has hitherto not been associated with an increased risk of cancer. However, recent studies, using a m

HFE Cys282Tyr homozygotes with serum fer
✍ Katrina J. Allen; Nadine A. Bertalli; Nicholas J. Osborne; Clare C. Constantine; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Hemochromatosis gene (HFE)-associated hereditary hemochromatosis (HH) is a genetic predisposition to iron overload and subsequent signs and symptoms of disease that potentially affects approximately 80,000 persons in Australia and almost 1 million persons in the United States. Most clinical cases ar

Variant genotypes of CDKN1A and CDKN1B a
✍ Hongxia Ma; Guangfu Jin; Zhibin Hu; Xiangjun Zhai; Wensen Chen; Shui Wang; Xuech 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Abstract p21^Cip1^ and p27^Kip1^ are cyclin‐dependent kinase inhibitors, which can arrest cell proliferation and serve as tumor suppressors. Reduced protein expression of p21^Cip1^ and p27^Kip1^ was frequently observed in a subset of cancers, including breast cancer. In this study, we hypothesiz

Functional variants in the promoter of i
✍ Jiyong Liu; Xiangjun Zhai; Guangfu Jin; Zhibin Hu; Shui Wang; Xuechen Wang; Jian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 1 views

## Abstract Interleukin 1β (IL‐1β) is a multifunctional cytokine that upregulates the inflammatory response, and participates in carcinogenesis, malignant transformation, tumor growth, invasion and metastasis. Two potentially functional polymorphisms (T‐31C and C‐511T) in the __IL‐1__β gene promote